Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
Part of paid clinical trials in Columbia, South Carolina.
- Sponsor
- University of South Carolina
- Study ID
- NCT05370014
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
- Chronic Disease
- Chronic Kidney Diseases
- Diabetes Mellitus, Type 2
- SARS- CoV-2
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) — BEHAVIORALThe intervention consists of two planning sessions with the dyad (over 2 weeks) followed by eight topic-guided sessions delivered the RN-CHW team over 12 weeks (weekly the first 4 weeks, then bi-weekly) (Table 3). Key components of these televisits include COVID-19 risk mitigation, chronic disease management, medication adherence, family functioning/support, and community and health systems resource identification and referral with ongoing goal planning. The RN-CHW will meet weekly for progress review, follow up planning, and setting up anticipatory guidance for the next session with the dyads. The RN and CHW will also review IC or survivor dissatisfaction and other issues that require more immediate attention. RN-CHW planning will be assessed to make sure each televisit remain topic focused yet incorporates flexibility to suit the needs of each dyad.
Study Details
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Key Dates
- Start date
- Jan 3, 2023
- Status verified
- May 2025
- Primary completion
- May 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: iCINGS Fam InterventionIntegrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) is 14-week, nurse coordinated, Community Health Worker (CHW) supported telehealth intervention structure. After baseline assessment, dyads randomized to the intervention group (n= 125 dyads) will have two planning sessions (over 2 weeks) followed by eight topic-guided sessions delivered by a member of the RN-CHW team over 12 weeks (weekly the first 4 weeks, then bi-weekly), Follow up assessments will occur at month 4 and month 7.
- No Intervention: Attention ControlAfter baseline assessment, dyads randomized to the attention control group (n= 125 dyads) will receive monthly (3 in total; 7-10 min each) scripted phone calls on focused on general health risks and health promotion. Monthly telephone calls will cover readily accessible evidence-based public health messaging from the Centers for Disease Control and Prevention (CDC) Your Health, NIH and other public health community facing websites related to COVID-19 mitigation such as risk reduction and prevention strategies including flu vaccines, asymptomatic spread, and contact tracing. Follow up assessments will occur at month 4 and month 7.
Primary Outcome Measure
Change in patient-reported outcomes measurement information system (PROMIS) Global Health Scale [ Time Frame: 0, 4, 7 months ]
Central Contacts
- Study PI8037779160
- Program Coordinator(803) 576-7787
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of South Carolina | Columbia | South Carolina | 29208 |
Find similar trials in Columbia, SC
By condition
By research site
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Escitalopram and Language Intervention for Subacute AphasiaPHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Telerehabilitation for Aphasia (TERRA)Recruiting · University of South Carolina · Columbia, South Carolina